BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marty VN, Farokhnia M, Munier JJ, Mulpuri Y, Leggio L, Spigelman I. Long-Acting Glucagon-Like Peptide-1 Receptor Agonists Suppress Voluntary Alcohol Intake in Male Wistar Rats. Front Neurosci 2020;14:599646. [PMID: 33424537 DOI: 10.3389/fnins.2020.599646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Mahajan VR, Elvig SK, Vendruscolo LF, Koob GF, Darcey VL, King MT, Kranzler HR, Volkow ND, Wiers CE. Nutritional Ketosis as a Potential Treatment for Alcohol Use Disorder. Front Psychiatry 2021;12:781668. [PMID: 34916977 DOI: 10.3389/fpsyt.2021.781668] [Reference Citation Analysis]
2 Keller BN, Hajnal A, Browning KN, Arnold AC, Silberman Y. Involvement of the Dorsal Vagal Complex in Alcohol-Related Behaviors. Front Behav Neurosci 2022;16:801825. [DOI: 10.3389/fnbeh.2022.801825] [Reference Citation Analysis]
3 Shevchouk OT, Tufvesson-Alm M, Jerlhag E. An Overview of Appetite-Regulatory Peptides in Addiction Processes; From Bench to Bed Side. Front Neurosci 2021;15:774050. [PMID: 34955726 DOI: 10.3389/fnins.2021.774050] [Reference Citation Analysis]
4 Zhao J, Zhao Y, Hu Y, Peng J. Targeting the GPR119/incretin axis: a promising new therapy for metabolic-associated fatty liver disease. Cell Mol Biol Lett 2021;26:32. [PMID: 34233623 DOI: 10.1186/s11658-021-00276-7] [Reference Citation Analysis]
5 Merkel R, Moreno A, Zhang Y, Herman R, Ben Nathan J, Zeb S, Rahematpura S, Stecyk K, Milliken BT, Hayes MR, Doyle RP, Schmidt HD. A novel approach to treating opioid use disorders: Dual agonists of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors. Neurosci Biobehav Rev 2021;131:1169-79. [PMID: 34715149 DOI: 10.1016/j.neubiorev.2021.10.026] [Reference Citation Analysis]